There is no established genetic model of bipolar disorder or major depression, which hampers research of these mood disorders. Although mood disorders are multifactorial diseases, they are sometimes manifested by one of pleiotropic effects of a single major gene defect. We focused on chronic progressive external ophthalmoplegia (CPEO), patients with which sometimes have comorbid mood disorders. Chronic progressive external ophthalmoplegia is a mitochondrial disease, which is accompanied by accumulation of mitochondrial DNA (mtDNA) deletions caused by mutations in nuclear-encoded genes such as POLG (mtDNA polymerase). We generated transgenic mice, in which mutant POLG was expressed in a neuron-specific manner. The mice showed forebrain-specific defects of mtDNA and had altered monoaminergic functions in the brain. The mutant mice exhibited characteristic behavioral phenotypes, a distorted day-night rhythm and a robust periodic activity pattern associated with estrous cycle. These abnormal behaviors resembling mood disorder were worsened by tricyclic antidepressant treatment and improved by lithium, a mood stabilizer. We also observed antidepressant-induced mania-like behavior and long-lasting irregularity of activity in some mutant animals. Our data suggest that accumulation of mtDNA defects in brain caused mood disorder-like mental symptoms with similar treatment responses to bipolar disorder. These findings are compatible with mitochondrial dysfunction hypothesis of bipolar disorder.
Introduction
Mood refers to a prolonged emotion that colors the whole psychic life. As mood is difficult to unequivocally define in non-human animals, an animal model of human mood disorder may help the understanding of biological background of mood. In Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV, 1 mood disorders are divided into bipolar disorders, major depressions, and others. The lifetime prevalence of mood disorders is considerably high; for example, 10-15% for major depression and about 1% for bipolar disorder.
Family, twin, and adoption studies have strongly suggested a genetic contribution to the onset of mood disorders, particularly bipolar disorder; however, the etiologies remain largely enigmatic. 2, 3 As a potential etiology of the disorder, we have been focusing on mitochondrial dysfunction 4 that was initially suggested by altered energy metabolism in the brains of patients as detected by magnetic resonance spectroscopy (MRS). 5 Genetic analyses of mitochondrial DNA (mtDNA) demonstrated a significant association between several mtDNA polymorphisms or mutations and bipolar disorder. [6] [7] [8] MtDNA, inherited only from the mother, contains two ribosomal RNA genes, 22 transfer RNA genes, and 13 protein-encoding genes. All of the 13 gene products function in the mitochondrial respiratory (electron transport) chain; and, in addition to the mtDNA-encoded proteins, a great number of nuclear genome-encoded proteins are sorted into and function in the mitochondria. Recently, the contribution of such mitochondrial protein-encoding nuclear genes to bipolar disorder was revealed by a genetic study 9 and also by genome-wide gene expression analyses. 10, 11 Patients with bipolar disorder sometimes show somatic symptoms characteristic to mitochondrial diseases, such as ptosis, myophathy, headache, diabetes, etc. 7 Diabetes mellitus and migraine are especially known to comorbid frequently with the disorder. 12 Conversely, in some pedigrees with hereditary chronic progressive external ophthalmoplegia (CPEO), a mitochondrial disease caused by multiple deletions of mtDNA, affected members have comorbid mood disorders (Table  1) . 13, 14, 17, 18, 20, 21 Deleted mtDNA was detected in the postmortem brains of bipolar patients, 22 and MRS features in bipolar disorder 23, 24 resembled those seen in CPEO. 25, 26 These findings prompted us to propose 'mitochondrial dysfunction hypothesis of bipolar disorder', 4 and other researchers have recently supported this hypothesis. 10, 27, 28 On the basis of the hypothesis, we planned to develop a genetically engineered mouse carrying mtDNA deletions in the brain as an animal model. Although there had been no report describing causative genes for CPEO comorbid with mood disorders when we started this study in 2001, the point mutation D181A of mouse mtDNA polymerase (POLG) was reported to ablate the 3 0 -5 0 exonuclease activity without affecting the polymerase activity and to cause mtDNA deletions. 29 We generated transgenic (Tg) mice expressing this proofreading-deficient POLG in the brain. If mtDNA is affected in the whole body, the mice would suffer from myopathy and other physical disorders as observed in patients with mitochondrial diseases. Actually, a mutant POLG knock-in mouse with accumulating mtDNA defects in the whole body has been recently proven to show a variety of physical symptoms. 30, 31 Thus, the promoter of Ca 2 þ /calmodulin-activated protein kinase II a (CaMKIIa), a neuron-specific promoter, 32 was used. After we generated the Tg mice, three genes, mtDNA helicase (Twinkle), adenine nucleotide translocator on the inner membrane of mitochondria (ANT1), and POLG, were reported to cause hereditary CPEO comorbid with mood disorders (Table 1) .
Mood disorder is clinically diagnosed by psychiatrists solely based on the symptoms detected by clinical interviews, because there is no established biological marker (i.e. endophenotype). DSM-IV-TR (American Psychiatric Association) 1 and International Classification of Diseases (ICD)-10 (World Health Organization) 33 are most widely used as diagnostic criteria for mood disorders at the present time, but such criteria are difficult to apply straightforward to non-human animals. Thus, the following three validations have been proposed to appraise animal models: 34, 35 (1) face validity, commonalties between the behavioral features of the model and of the human disorder being modeled; (2) construct validity, a possible common mechanistic theory that can explain both the model and the human disorder; and (3) predictive validity, the efficacy of treatment drugs used for human disease for the phenotype of the model animal. In this study, we demonstrated mood disorder-like characteristics of the Tg mice with neuron-specific mtDNA defects in accordance with the validations.
Materials and methods

Generation of transgenic mice
A cDNA for mouse POLG was cloned from whole-brain mRNA of C57BL/6J mouse. There were several differences in nucleotide sequence and deduced amino-acid sequence, between the cDNA we cloned and the sequence that had been recorded in the databases (DDBJ/EMBL/GenBank accession number, U53584; version U53584.1). Based on the mouse genome sequence (NT_039428, Mus musculus chromosome 7 genomic contig) and comparison with POLG cDNAs of other mammalian species, we concluded that the recorded sequence contained sequencing errors and we deposited the sequence we determined to the public database under accession number AB121698.
The aspartate residue at position 181 of mouse POLG was replaced with an alanine by QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) using the following oligonucleotide primers: 5 0 -GCC CTG GTG TTC GCC GTG GAG GTC TGC-3 0 and 5 0 -GCA GAC CTC CAC GGC GAA CAC CAG GGC-3 0 . For the convenience of the transgene construction, two NotI restriction enzyme digestion sites in the POLG coding sequence (CDS) were removed by site-directed mutagenesis without altering the amino-acid sequence using the following oligonucleotide primers: 5 0 -GTC CCC AGC GAC GGT CGG CCG CCG TC-3 0 , 5 0 -GAC GGC GGC CGA CCG TCG CTG GGG AC-3 0 ; and 5 0 -CCT TAC TTG GAG GCT GCC GCC TCG-3 0 , 5 0 -CGA GGC GGC AGC CTC CAA GTA AGG-3 0 . The mutant POLG CDS was amplified by PCR using the following primers containing either XhoI or SfiI site: 5 0 -CTC GAG CCA TGA GCC GCC TGC TCT GGA AGA AG-3 0 and 5 0 -GGC CAA TTG GGC CTT CCG TTA GGA GGA C-3 0 . After subcloning and checking of the sequence, the XhoI-SfiI fragment was isolated, blunt-ended, and inserted into the EcoRV site of pNN265 (a gift from Dr Mark Mayford) to give rise to pNN265-mutPOLG. A NotI fragment containing the SV40 small-T antigen intron and early polyadenylation sequences as well as the mutant POLG CDS was isolated from pNN265-mutPOLG and inserted into pMM403 plasmid (a gift from Dr Mark Mayford), which contains the promoter of mouse Ca 2 þ /calmodulin-activated protein kinase II a (CaMKIIa). 32 The final plasmid pMM403-mutPOLG was maintained in Stbl2 cells (Invitrogen) incubated at 301C. The linearized transgene construct, released from the plasmid vector by SfiI digestion, was microinjected into 894 fertilized eggs from C57BL/6J mice, and the transgenic offspring were screened by PCR using the following primers: 5 0 -TTG AGG TTT TCC AGC AGC AG-3 0 and 5 0 -AAG GAC TCG ATG GCT CTG TAG G-3 0 . Three transgenic offspring were obtained by the screening of 27 weaned pups.
The Animal Experiment Committee of RIKEN approved all animal experiment protocols. Transgenic mice were always used as heterozygotes, and controls were non-Tg littermates as far as possible. Female Tg mice were not used for breeding in order to prevent transmission of mutated mtDNA from mothers to pups, although expression of the transgene is restricted in neuronal tissues. Therefore, only male Tg mice were mated with wild-type mice (C57BL/6J) purchased from CLEA Japan (Tokyo, Japan).
Transgene mRNA expression analysis Total RNAs were extracted from five areas of the brain (frontal lobe, hippocampus, (other) cortex, basal ganglia, and cerebellum) and various somatic tissues using TRIzol reagent (Invitrogen). DNase I-treated total RNA was reverse-transcribed using the anchor oligo(dT) primer (5 0 -TTT TTT TTT TTT TTT TV-3  0 ) , and the cDNA was used for quantification of relative mRNA levels detected by real-time PCR technology with SYBR Green PCR Master Mix (Applied Biosystems). The relative levels of each mRNA were calculated by 2 ÀCT (CT standing for the cycle number at which the signal reached the threshold) and normalized to the corresponding GAPDH mRNA levels. Each CT value used for these calculations was the mean of quadruplicate of the same reaction. Before we performed this assay for POLG mRNA expression, we developed two pairs of PCR primers that annealed at the site-direct mutagenesis positions and amplified specifically either mutant (transgenic) or wild-type (endogenous) POLG cDNA. The following primers were used: mutant POLG primers, 5 0 -CTG CCT TAC TTG GAG GCT-3 0 and 5 0 -CAA GCA GAC CTC CAC GG-3 0 ; wild-type POLG primers, 5 0 -CTG CCT TAC TTG GAG GCG-3 0 and 5 0 -CAA GCA GAC CTC CAC GT-3 0 ; and GAPDH primers 5 0 -TGC ACC ACC AAC TGC TTA G-3 0 and 5 0 -GGA TGC AGG GAT GAT GTT C-3 0 .
Assessment of mtDNA deletions and mutations in mouse tissues Southern blot analysis. DNA was isolated from mouse tissues of various ages using automatic DNA isolation system PI50 (Kurabo, Osaka, Japan) and digested with BglII, which cuts once the C57BL/6J mouse mtDNA (AY172335). The digested DNA (4 mg per lane) was electrophoresed on 0.8% agarose gel, treated with 0.25 M HCl for 5 min, and transferred onto a nylon membrane (Hybond-N þ , Amersham Biosciences) by capillary blotting with 0.4 M NaOH. The membranes were hybridized with a digoxigenin (DIG)-labeled DNA probe at 421C overnight in DIG Easy hybridization buffer (Roche Diagnostics GmbH, Mannheim, Germany) following to pre-hybridization with the same buffer at 421C for 1 h. The hybridized membrane was washed at 681C in 0.5 Â SSC, 0.1% SDS, and hybridization signals were detected by using DIG Luminescent Detection Kit (Roche Diagnostics) and a luminescent image analyzer (LAS-3000, Fujifilm, Tokyo, Japan). DIG-labeled DNA probes for control region of mouse mtDNA were prepared from plasmid clones by using PCR DIG Probe Synthesis Kit (Roche Diagnostics). The control region was isolated by PCR from liver DNA of a C57BL/6J mouse using the following primer set: 5 0 -GCT AGT ACA TTA AAT CAA TGG TTC AGG-3 0 and 5 0 -CTA CTA GAA TTG ATC AGG ACA TAG G-3 0 . The PCR products amplified with LA Taq DNA polymerase (Takara Bio, Shiga, Japan) were cloned in pCR2.1-TOPO plasmid vector (Invitrogen) and verified the sequences. These primers were also used to prepare DIG-labeled probes using PCR DIG Probe Synthesis Kit.
PCR amplification, cloning, and sequencing of small mtDNA. Three sets of PCR primers, of which 3 0 ends were almost adjacent, were designed to anneal to the control region of mouse mtDNA as follows: set A, 5 0 -GCT AGT ACA TTA AAT CAA TGG TTC AGG-3 0 and 5 0 -CGA TAT ACA TAA ATG TAC TGT TGT ACT ATG-3 0 ; set B, 5 0 -GTC TAG ACG CAC CTA CGG TG-3 0 and 5 0 -TGT GTG CTG TCC TTT CAT GCC-3 0 , and set C, 5 0 -AAC TCT AAT CAT ACT CTA TTA CGC-3 0 and 5 0 -CTA CTA GAA TTG ATC AGG ACA TAG G-3 0 . Using these primer sets, short-extension PCR was employed to amplify small mtDNAs. The thermal cycling protocol used was 951C for 20 s, 551C for 30 s, 721C for 90 s for 28-30 cycles. LA Taq DNA polymerase was used when the PCR products were subsequently cloned and sequenced; or otherwise Ex Taq DNA polymerase (Takara Bio) was used. The PCR products were cloned into pCR2.1-TOPO plasmid vector and sequenced.
Mutation search in mtDNA. MtDNA fragments corresponding to the control region and ND4-coding region were amplified from DNA extracted from the hippocampus of a 68-week-old Tg mouse or a non-Tg littermate by PCR using the same primers described in above Southern blot analysis. The PCR products amplified with PfuUltra DNA polymerase (Stratagene) were cloned in pCR-blunt II-TOPO plasmid vector (Invitrogen), and sequenced. We performed PCR and cloning two times and sequenced total B100 independent clones to analyze the Tg sample.
Conventional behavioral tests
Procedures for the behavioral tests are provided in the Supplementary information.
Quantitative determination of monoamines and their metabolites Three weeks after the conventional test battery, the male mice (n = 8 for each genotype) were also used for the analysis of monoamine levels. After decapitation, each brain region was dissected on ice, and stored at À801C until use. Tissues were homogenized by an ultrasonic homogenizer following addition of an internal standard (isoproterenol) and perchloric acid. After centrifugation, pH of the filtered supernatant was adjusted by sodium acetate. The contents of monoamines and their metabolites were determined using an HPLC system with an electrochemical detector as described previously. 36 Long-term recording of wheel-running activity and analysis Mice were individually housed in cages (24 cm wide Â 11 cm deep Â 14 cm high) equipped with a steel wheel (5 cm wide Â 14 cm in diameter). Wheelrunning activity (3 counts per rotation) was monitored by an online PC computer system (O'Hara & Co., Tokyo, Japan). LD 12:12 h cycles (lights on at 0800 JST) were controlled by an automatic timer. Light was provided by a white fluorescent tube and the light intensity was 30-50 lux at the level of mouse's eyes in the cage. Food and water were available ad libitum at all time. We supplemented or changed water and food towards the end of the light period. In the case of females, only virgin mice were used. Some of mice did not learn the wheel running at all or stopped for several days presumably due to obstruction by chips for bedding. Data from these mice were not used in the following analyses. In addition, since it takes about 1 week till mice were used to the wheel running, data of the first 7-10 days of each recording were omitted.
Delayed and anticipatory activity indices. Delayed activity index is defined as a percent of the activity during the first 3 h of the light period with the total activity during the previous dark period (12 h). Anticipatory activity index is defined as a percent of the activity during the last 3 h of the light period with the activity during the following dark period (12 h).
Lomb-Scargle periodogram. To detect periodic components with duration of 4-5 days in the wheelrunning activity of female mice, we used the LombScargle periodogram, a modified method of the Fourier spectrum analysis. 37 Day-to-day variation. Day-to-day variation in wheelrunning activity was estimated by the unevenness in daily wheel-running activity that is a total number of counts of wheel running per day. Day-to-day variation during a certain period (days 1-N) is calculated as follows:
aðiÞ where a(n) indicates a daily wheel-running activity of day n, and m is a mean value of daily wheel-running activities
Drugs Amitriptyline (AMT) hydrochloride (Sigma-Aldrich, St. Louis, MO, USA) was administered in drinking water at a concentration of 200 mg l
À1
. The plasma level of AMT after 10-days administration was examined by HPLC in a preliminary experiment (JCL Bioassay, Nishiwaki, Japan). The level of AMT was 7.979.1 ng ml À1 . Lithium was administered in the diet at a concentration of 2.4 g Li 2 CO 3 per 1 kg dry food (Oriental Yeast Co., Tokyo, Japan). In a preliminary experiment, we administered Li 2 CO 3 -containing diet at various concentrations (1.6, 2.0, and 2.4 g kg
) to C57BL/6J mice for 4 weeks. The plasma levels of Li þ , measured by atomic absorption spectroscopy (SRL Inc., Tokyo, Japan), were 0.4270.11 mM (mean7s.d.), 0.5170.05, and 0.6370.17, respectively. The amount of drinking water consumed by mice given the Li 2 CO 3 -containing diet (2.4 g kg À1 ) was approximately 2.5 times more than the control mice eating a normal diet.
Results
Generation of transgenic mice with accumulating mtDNA mutations in the brain We designed a transgene construct comprising a coding sequence for the mutant mouse POLG (mPOLG) (D181A) operatively linked to the CaMKIIa promoter ( Figure 1a ) and generated Tg mice using a standard method. Among three lines (A, B, and C) of Tg mice established, mutant mPOLG mRNA was most abundantly expressed in the brain in line B, weakly in line C, and only marginally in line A (data not shown). Hence, line B was used to analyze in detail. We analyzed the mPOLG expression in the various tissues of mice (20 weeks old) of line B by quantitative RT-PCR. The transgenic mutant mPOLG mRNA was as abundant as the endogenous (wild-type) mPOLG mRNA in the most parts of forebrain, and the mutant mPOLG expression was nearly restricted in the brain (Figure 1b) .
MtDNA defects in the brain of transgenic mice
We first performed Southern blot analysis to assess mtDNA deletions in the Tg mice. Using a probe for the control region of mtDNA (see Figure 1d ), deleted mtDNAs of approximately 2 kb were found in the brain (frontal lobe, hippocampus, other cortex, and basal ganglia) of 68-week-old Tg mouse (Figure 1c) . The small mtDNAs were not found in the non-Tg littermate, and neither in the other tissues of the Tg mouse, such as cerebellum, liver, and kidney. In another independent experiment using much older Tg mice (98 weeks old), the deleted mtDNAs were surely detected in the forebrain but not in the somatic tissues, liver, heart, and skeletal muscle (data not shown). This tissue-specific occurrence of the small mtDNA was in accordance with the expression pattern of mutant POLG mRNA in Tg mice ( Figure  1b) . We also assayed younger mice and found the small mtDNAs in Tg mice of 17, 23, and 38 weeks old, but not in 8-week-old Tg mice and in any non-Tg littermates (Supplementary Figure S1) . The deleted mtDNA was accumulated first in the hippocampus and cortex (17 weeks old). This may also be accounted for by the tissue-dependent difference in mutant POLG expression level (Figure 1b) . The small mtDNAs (0.5-2.5 kb) were cloned by PCR and sequenced, revealing that the deletion breakpoints (rearrangement points) had diverse sequences ( Figure  1d and Supplementary Figure S2) . Next, we investigated whether point mutations of mtDNA were accumulated in the brain of Tg mice. The control region of mtDNA was amplified by PCR using DNA extracted from 68-week-old littermates as a template and cloned into a plasmid vector. We sequenced approximately 100 clones and found point mutations in the Tg mouse (6 of 48,114 bases), but not in the non-Tg littermate (0 of 23,814 bases). The content of mtDNA was not influenced in the Tg mice by overexpression of POLG, though deletions and mutations in mtDNA were accumulated (Figure 1c) .
Conventional behavioral tests
The Tg mice weighed approximately 10% less than their non-Tg littermates (Supplementary Figure S3a) . We measured voluntary food intake and body weight in male Tg and their non-Tg littermates (21-28 weeks old, n = 10 for each genotype) and observed that Tg mice ate less than non-Tg mice (Supplementary Figure S3b) . However, there was no significant difference in food intake per body weight between the genotype, suggesting that lower body weight of Tg mice corresponded to reduced food intake. The Tg mice did not differ from their non-Tg littermates in physical health, fertility, and longevity except for lower weight; and no gross abnormality of brain structure was noted by visual or microscopic inspection.
Motor function and fatigue resistance assessed by rotarod and treadmill tests, respectively. The tests were performed with 22-29-week-old male mice. There was no significant difference in these performances between Tg and non-Tg mice (Supplementary Figure S4) , indicating that the Tg mice have normal motor coordination and normal fatigue resistance.
We tested the emotional behaviors and learning/ memory functions of Tg mice. This test battery was performed with 18-27-week-old male mice. In the open field test, there was no significant difference between Tg and non-Tg mice in ambulatory activity (Figure 2a) as well as in numbers of grooming, rearing, jumping, defecation, and urination (data not shown). Elevated plus-maze test also showed no significant difference between genotypes (Figure 2b ). On the other hand, the amplitude of the acoustic startle response was significantly increased in Tg mice (Figure 2c ). In the forced swimming test, a screening for antidepressants, there was no significant difference in immobility time between genotypes ( Figure   2d ). Novel-object recognition test (Figure 2e ) and conditioned fear learning test (Figure 2f ) did not show detectable differences in the learning/memory functions between Tg and non-Tg mice. It is noteworthy that we found an augmentation of freezing response in Tg mice in the conditioning phase of the conditioned fear learning test.
Monoamine contents and turnover in the brain
To examine biochemical similarity of the Tg mice to patients with mood disorders, we analyzed the contents of monoamines and their metabolites in male Tg mice and the littermates of 22-32 weeks old. Six regions of brain (prefrontal cortex, hippocampus, amygdala, striatum, hypothalamus, and nucleus accumbens) were dissected, and contents of serotonin (5-HT), noradrenaline (NA), dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic Values from individual animals (circles), each of which is an average of 21-27 days, are shown. Transgenic mice showed significantly higher scores of the delayed activity index (*P < 0.0001, MannWhitney U-test), indicating that they continued to move after the dark period was finished. (e) Anticipatory activity estimated by comparing the activity during the last 3 h of the light period with the activity during the following dark period. Transgenic mice showed significantly higher scores of the anticipatory activity index (**P < 0.005). acid (HVA), and 5-hydroxyindoleacetic acid (HIAA) were measured ( Table 2) . Level of 5-HT was significantly decreased in the amygdala (67%) and hippocampus (86%) of Tg mice compared with non-Tg littermates. Serotonin turnover, assessed by the ratio of 5-HIAA to 5-HT (5-HIAA/5-HT), was significantly increased in both the regions. Decreased level of NA was also found. DA was increased in the hippocampus of Tg mice, whereas decreased in the amygdala. DA turnover, assessed by DOPAC/DA or HVA/DA, was increased in the amygdala and decreased in the hippocampus.
Long-term recording of wheel-running activity
Male Tg mice and their non-Tg littermates were maintained on a 12-h light/12-h dark (LD) cycle, and their wheel-running activities were recorded for more than 1 month. While no apparent periodic change in wheel-running activity was observed up to 2 months' recording (Figure 3a) , total wheel-running activity was significantly smaller in Tg mice compared with their littermates (P < 0.0001) (Figure 3b ). Moreover, we found that the Tg mice exhibited quite a distinct pattern of within-a-day activity. Tg mice showed continued activity after the light was on and untimely activity before the light off, in contrast to non-Tg mice, which had clear day-night variation (diurnal rhythmicity) (Figure 3c and Supplementary Figure S5) . To analyze the phenomena quantitatively, we defined 'delayed activity index' and 'anticipatory activity index'. These are the rates of the activity level in the first and last 3 h of the light period, respectively, to that in the successive 12-h dark period. Transgenic mice showed significantly higher scores of both delayed and anticipatory activity indices (P < 0.0001 and P < 0.005, respectively) (Figure 3d and e) . To test whether this was caused by impairment of the circadian clock machinery or not, we recorded the wheel-running activity under the constant dark condition. There was no significant difference in free-running period (Tg, 23.8270.14 h (mean7s.d.); and non-Tg, 23.8270.10 h), and Tg mice never exhibited arrhythmic activity over 1 month in constant darkness (see Supplementary Figure S7 ).
Tricyclic antidepressant-induced activity change in transgenic mice
While tricyclic antidepressants are effective for major depression, it is liable to cause antidepressantinduced mania in bipolar disorder. 38 To test the behavioral consequence of tricyclic antidepressant in the Tg mice, we orally administered amitriptyline (AMT). During the course of preliminary experiments, we found that addition of AMT into drinking water (0.02%) reduced the water intake and sometimes disturbed physical health in mice. Supplementation of saccharin to AMT-containing water reportedly improves water intake. 39 Hence, we performed two experiments; one was comparison between distilled water with and without AMT, and the other was comparison between saccharin (2%)-containing water with and without AMT. In the former experiments, AMT in drinking water was administered for 7 or 10 days to minimize the effects on physical health caused by dehydration. In the latter experiment, saccharine-containing water with or without AMT was administered for 17 days.
In the experiment using addition of saccharin, Tg mice showed significant worsening of both delayed and anticipatory activity indices by AMT treatment (Figure 4a-c) . AMT did not affect non-Tg mice. Two of eight Tg mice and one of five non-Tg mice could not survive the experiments of AMT in drinking water without saccharin possibly due to dehydration. As a result of the high incidence of death and disturbed general health, a statistical analysis was not applied to this experiment. Among the six surviving Tg mice, two mice administered with AMT for 10 days showed antidepressant-induced mania-like behavioral change. Both mice exhibited prominent wheelrunning activity for several hours in the light period on the 4th or 7th day of AMT treatment ( Figure 4e , day 20). After this, one mouse became markedly hyperactive than before, and this hyperactive state lasted at least 3 weeks (Figure 4e ). This manic switchlike phenomenon was not seen in non-Tg mice. In the experiment using addition of saccharin, AMT treatment significantly increased wheel-running activity level after the termination of the treatment compared with saccharin (P < 0.02) (Figure 4d ). Estrous cycle-associated fluctuation in wheel-running activity of female transgenic mice We also measured long-term wheel-running activity in female Tg mice. As shown in Figure 5a , cyclic activity change with a period of 4-5 days was observed in most of the Tg mice, but hardly in nonTg mice (Supplementary Figure S6) . The statistically significant periodicity of activity, calculated by Lomb-Scargle periodogram, 37 was more frequently seen in Tg mice (9-45 weeks old) compared with nonTg (24 of 26 Tg mice tested vs 2 of 9 non-Tg mice; P < 0.0002, Fisher's exact probability test). This cyclic activity change with a period of 4-5 days in the Tg mice was maintained in the constant dark condition (Supplementary Figure S7) . Since the observed period length was similar to that of the estrous cycle of mice and this periodicity in Tg mice disappeared after ovarectomy (data not shown), we concluded that the fluctuation with a period of 4-5 days was associated with the estrous cycle. Transgenic mice of 9-40 weeks old showed this periodicity, which was most prominent at 30-40 weeks after birth, and the fluctuation almost disappeared at the age of 60 weeks (Figure 5b ). Estrous cycle of female C57BL/6 mice becomes irregular around 40-56 weeks after birth and ceases at 72-80 weeks. 40 In the Tg mice, activity was higher in the proestrus and lower in the other stages, estrus, metestrus, and diestrus (Figure 5c ). The delayed activity increased during the estrus, metestrus, and diestrus (Figure 5c, arrows) , when wheelrunning activity was reduced. Similarly to the case of male mice (Figure 3b) , average wheel-running activity was significantly smaller in female Tg mice than nonTg mice (P < 0.00005) (Figure 5d ).
Some female Tg mice (approximately 5%) exhibited marked variability in the wheel-running activity rhythm with a longer time frame. Two case reports are presented in Supplementary Figure S8 .
Lithium attenuates the cyclic activity change of female transgenic mice Lithium is the first choice treatment for both bipolar depression (depressive state of bipolar disorder) and mania, 41 and is also used for treatment resistant major depression as augmentation therapy. 42 After the baseline measurement of wheel-running activity for 4 weeks, a diet containing lithium carbonate (0.24%) was given to the female Tg mice (23-34 weeks old at the beginning of the recording) for additional 4 weeks. Periodic activity fluctuation gradually diminished after lithium treatment (Figure 6a ). During 1-3 weeks after lithium administration, none of seven Tg mice treated with lithium had statistically significant (P < 0.05) periodicity of 4-6 days (96-144 h), while five of six control Tg mice given a normal chow had significant periodicity (P < 0.005, Fisher's exact probability test) (Supplementary Figure S9) . Day-to-day variation in the wheel-running activity (see Materials and Methods) was found to be decreased significantly in the Tg mice treated with lithium compared with those receiving a control diet (P = 0.046) (Figure 6b) . Improvement of the delayed activity index tended to be better in the Tg mice treated with lithium than those receiving a normal control diet (Figure 6c) . The change in wheel-running activity before and after the treatment did not differ between lithium-containing and control diets (Figure 6d ). The palliative effect of lithium on the cyclic activity change was consistently observed in two independent experiments.
Discussion
In this study, we developed mutant POLG Tg mice with neuron-specific accumulation of mtDNA defects and analyzed the behavioral characteristics of the mice. We would like to propose that the genetically engineered mice fulfill all of the following three criteria for the validity as an animal model of mood disorder.
Construct validity
We generated the mutant POLG Tg mouse based on the several lines of evidence; mood disorder is a characteristic symptom of CPEO in some pedigrees (Table 1) , and patients with bipolar disorder have altered brain energy metabolism 23, 24 and deleted mtDNA in the brain 22 as observed similarly in CPEO patients. In the Tg mice, deletions and mutations of mtDNA were produced in the forebrain as expected (Figure 1c, d and Supplementary Figure S1 ), indicating that the Tg mice closely mimic the CNS involvement of CPEO patients and bipolar patients with Wheel-running activity in a 10-min bin of each mouse is averaged over more than 2 weeks, and values from individual animals (circles) are shown. The Tg mice showed significantly lower wheel-running activity (*P < 0.00005; Mann-Whitney U-test). Transgenic mice with very low activities were more frequently observed in males (Figure 3b ) than females. suspected mitochondrial dysfunction. Recently, we found rare missense mutations of POLG causing mtDNA defects in a few patients with bipolar disorder (unpublished data). Therefore, the strategy of developing the mutant POLG Tg mice is most likely to be adequate to satisfy the construct validity. We suppose A genetic animal model for mood disorder T Kasahara et al Figure 6 Effects of lithium on the abnormal pattern in wheel-running activity of female transgenic (Tg) mice. (a) Individual time course of total wheel-running activity per day. Lithium was given in diet (0.24%) as a carbonate salt (Li 2 CO 3 ) from day 27 until the end of the recording. Plasma lithium concentration was determined after the recording and is shown on each graph. (b) Improvement of day-to-day variation in wheel-running activity by lithium treatment. Day-to-day variation (F) was estimated on the basis of the activity levels before (F pre ) and during (F post ) the treatment (days 10-26 and 34-50, respectively). Values from individual animals (circles) as well as group average values (horizontal bars) are shown. Lithium diet significantly lowered the day-to-day variation of Tg mice compared with a control diet (*P < 0.05, Mann-Whitney U-test). that the mitochondrial dysfunction hypothesis can explain the pathophysiology of at least some portion of patients with bipolar disorder.
Face validity
By analyzing wheel-running activity for more than one month, we revealed that these Tg mice had distinctive behavioral abnormalities. One of the most prominent phenotypes of Tg mice is reduced wheelrunning activity (Figures 3b and 5d) . Wheel running is a voluntary behavior and self-reinforcing for rodents. 43, 44 According to the results of the conventional behavioral tests (Figure 2 and Supplementary  Figure S4 ), the reduced wheel-running activity is unlikely to be attributable to any abnormalities in sensorimotor systems, motor functions, or fatigue resistance. Lack of detection of mtDNA deletions in the skeletal muscles and heart also support this. Therefore, the Tg mice are likely to have reduced motivation for the voluntary activity. The Tg mice also showed altered intra-day activity rhythm, which was characterized by prolonged activity duration such as delayed and anticipatory activities ( Figure  3c -e and Supplementary Figure S5 ). Many lines of clinical evidence point out that mood disorder is accompanied by abnormality in circadian rhythm or daily day-night variation. For instance, depressive mood in the case of humans regularly worsens in the morning, and characteristic sleep disturbances including early morning awakening are observed. It might be supposed that the Tg mice with extensive delayed and anticipatory activities have mood disorder-like symptoms, though this should be interpreted with caution because mice are nocturnal animals but humans are not. Importantly, prolonged activity duration was exhibited in the period with lower activity levels (Figure 5c ). This apparently paradoxical pattern, that is, longer duration of activity accompanied by lower intensity of activity, corresponds to the activity pattern in human patients with depressive episode. 45 Mood disturbance is thought to be caused by alteration of monoaminergic neurotransmission in brain. 3, 46 The 'monoamine hypothesis' was mainly based on the action mechanisms of antidepressants and antimanic agents, and this has gradually been confirmed by clinical and postmortem brain studies. [47] [48] [49] In the brain of Tg mice, we found altered level and/or turnover of monoamines, 5-HT, DA, and NA (Table 2) . Chronic treatment with a tricyclic antidepressant-induced manic switch-like behavior in some Tg mice and worsened the distorted day-night rhythm ( Figure 4 ). Increased activity of the treated Tg mice after the termination of the treatment suggested that the influence of the drug was long-lasting as observed in patients with bipolar disorder, manic component of which is worsened by tricyclic antidepressants. 38 Moreover, female Tg mice showed estrous cycleassociated fluctuation in wheel-running activity (Figure 5a-c) . Robustness of the fluctuation was agedependent; it was most prominent around 30-40 weeks after birth and disappeared over 60 weeks old. This probably reflected the influence of both accumulation level of mtDNA defects (Supplementary Figure S1) and intensity of the estrous cycle. The estrous cycle-associated fluctuation may be implicated as a reduced ability to control their mood against the endocrinological perturbation and resemble the mood changes across the menstrual cycle observed in more than half of reproductive aged women with bipolar disorder. 50, 51 Therefore, the above-mentioned phenotypes of Tg mice with neuron-specific mtDNA defects are most relevant to recurrent major depression or bipolar depression. Predictive validity Currently, three mood stabilizers, lithium, valproate, and carbamazepine, are established as effective prophylactic treatment for bipolar disorder. Lithium, the first-choice drug for bipolar patients, improved the periodic activity change associated with the estrous cycle in female Tg mice and also the distorted day-night rhythm ( Figure 6 ), suggesting the predictive validity of the Tg mice. Because the lithium treatment did not decrease the level of wheel-running activity (Figure 6d ), the effect of lithium on the behavioral abnormalities of Tg mice cannot be explained by a nonspecific sedative action. As for the effect of lithium treatment on women with bipolar disorder, lithium mitigated effectively premenstrual tension syndrome 52 and had a prophylactic effect on premenstrual symptom changes in women with lithium-responsive bipolar disorder. 53 Viewed in this light, the therapeutic effect of lithium on the cyclic activity change of Tg mice would confirm the predictive validity as well as the face validity.
The responsiveness of Tg mice to a tricyclic antidepressant and lithium suggests that the behavioral phenotype of Tg mice are more similar to bipolar disorder rather than to major depression. Male Tg mice, however, did not show cyclic activity change (Figure 3a) . Prevalence of bipolar disorder is not different between men and women, although its severe phenotype, rapid cycling, is more frequent in women. 1 The POLG mutation presented in the Tg mice alone seems insufficient to cause biphasic mood disturbance. However, behavioral characteristics of the following cases of Tg mice appeared to be equivalent to the clinical phenotype of bipolar disorder: a male mouse (case 1) showing antidepressant-induced manic switch-like behavior (Figure 4e ) and female mice (cases 2 and 3) showing dysregulated long-term activity patterns (Supplementary Figure  S8) . In case 1, environmental insults such as antidepressant treatment and physical stress caused by dehydration, together with the genetic defect, might have caused this phenotype. In cases 2 and 3, the strange behavioral pattern started without any conceivable environmental insult. It would be the theme of future studies to identify the physiological, developmental, or environmental factors that can induce these prominent behavioral changes resembling manic and/or depressive episodes. Additionally, it would be worthwhile to discuss these anecdotal cases from the point of view of interindividual variability. Although such striking behavioral changes were rare, a large interindividual variability in the wheel-running activity was observed in the Tg mice in every experiment (e.g., Figure 3d , e and Supplementary Figure S5) . The proofreading-deficient POLG stochastically introduces a deletion or a point mutation in a mtDNA molecule in the neurons where the mutant POLG is expressed. Consequently, this leads interindividual variations in amount, types (Supplementary Figure S2) , and cellular/histological location of accumulated mtDNA defects.
Among the phenotypes of Tg mice, enhanced startle response ( Figure 2c ) and increased freezing in the conditioning phase of the fear-learning test (Figure 2f ) were prominent but apparently unrelated to mood disorders. Indeed, three papers reported normal startle reflex in euthymic patients with bipolar disorder. [54] [55] [56] On the other hand, enhanced startle response is reported in panic disorder or other anxiety disorders. 57 It is recently reported that more than half of patients with bipolar disorder comorbid with anxiety disorders such as panic disorder, and bipolar disorder with panic disorder may be a genetically distinctive phenotype. 58 It is intriguing to examine the possible relationship between mitochondrial dysfunction and comorbidity of panic disorder in bipolar disorder.
Several genetic and biochemical evidence indicate that mutations of POLG induce mtDNA defects including point mutations and multiple deletions (for human genetics, see references described below; for mouse genetics, Zhang et al. 29 , Trifunovic et al. 30 , Kujoth et al. 31 , and this study; for biochemical studies, Graziewicz et al. 59 and Spelbrink et al. 60 ). However, the relationship between the presence of mtDNA defects and the occurrence of specific clinical features of mitochondrial diseases still remains largely mysterious. In human patients carrying mutations in the POLG gene and consequent mtDNA defects, many associated phenotypes in addition to CPEO have been proposed; Parkinson's disease, 61 premature menopause, 61 ataxia, 62, 63 sensorimotor polyneuropathy, 64 deafness, 17 diabetes mellitus, 64 and mood disorders. 13, 17, 63 Furthermore, mutant POLG knock-in mice showed cardiomyopathy, alopecia, osteoporosis, anaemia, reduced fertility, etc. 30, 31 Thus, mtDNA defects and ensuing mitochondrial dysfunction enigmatically cause many kinds of phenotypes in various organs, suggesting that mutation in POLG is not a specific risk factor for mood disorder.
In order to understand the link between mitochondrial dysfunction and mood disturbance, we focus our attention on the role of mitochondria in Ca 2 þ regulation. Mitochondria are known to actively absorb and release Ca 2 þ to control intracellular Ca 2 þ levels. 65 Although it is difficult to investigate whether mitochondrial Ca 2 þ handling is impaired in the neurons of patients, altered Ca 2 þ signalings have been observed in the peripheral blood cells 66, 67 and recently reported in olfactory neurons obtained from bipolar patients. 68 These altogether raise a possibility that the mitochondrial dysfunction may affect the Ca 2 þ regulation and finally lead to mood disturbance. This possibility now becomes to be explored by using the mutant POLG Tg mice, which have a potential to fulfill the principal validities required for a model animal of mood disorder.
